All In MedTech

FDA Clearance Tracker · P970003-S197

Pulse, PulseDuo, DemiPulse, DemiPulseDuo, AspireHC, Aspire SR Generators.

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 28, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 28, 2016

Approved

Time to decision

86 days

Received May 3, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P970003-S197
Device name
Pulse, PulseDuo, DemiPulse, DemiPulseDuo, AspireHC, Aspire SR Generators.
Applicant location
Houston, TX
Received
May 3, 2016
Decided
Jul 28, 2016
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P970003

Device type

Device class
Class III

Every decision under product code LYJ

FDA's approval statement

As written in FDA's record.

Approval for changes to the labeling to update stimulation dosing strategies and modify ECG filter settings.

Source documents

Other decisions for LivaNova USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.